Top compounds associated with response to MADD


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.22 5e-10
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA PX-12 CTRPv2 pan-cancer AAC 0.17 1e-08
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.28 2e-08
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-07
Download CSV